West Pharmaceutical Services Inc (WST) Q4 2024 Earnings Call Highlights: Navigating Growth and ... [Yahoo! Finance]
West Pharmaceutical Services, Inc. (WST)
Last west pharmaceutical services, inc. earnings: 4/23 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investor.westpharma.com
Company Research
Source: Yahoo! Finance
4 min read In This Article WST Net Sales: $748.8 million in Q4, representing organic sales growth of 3.3%. Proprietary Products Organic Net Sales: Increased by 4.5% in Q4. Adjusted Operating Profit: $162.8 million in Q4, with a margin of 21.7%. Gross Profit Margin: 36.5% in Q4, down 150 basis points year-over-year. Adjusted Diluted EPS: Declined 0.5% for Q4. Operating Cash Flow: $653.4 million in 2024, a decline of $123.1 million from the previous year. Capital Expenditures: $377 million in 2024, a 4.1% increase over 2023. Cash Balance: $484.6 million as of December 31, 2024, a decrease of $369.3 million from December 2023. Share Repurchases: $560.9 million returned to shareholders in 2024. 2025 Net Sales Guidance: Expected to be in the range of $2.875 billion to $2.905 billion. 2025 EPS Guidance: Anticipated to be in the range of $6 to $6.20. 2025 CapEx Guidance: Expected to be $275 million, down $100 million from 2024. Q1 2025 Revenue Guidance: Anticip
Show less
Read more
Impact Snapshot
Event Time:
WST
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
WST alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
WST alerts
High impacting West Pharmaceutical Services, Inc. news events
Weekly update
A roundup of the hottest topics
WST
News
- West to Participate in Upcoming Investor ConferencePR Newswire
- West Declares Quarterly DividendPR Newswire
- West Pharmaceutical Services (NYSE:WST) was downgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=WST&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">WalMarketBeat
- The Bull Case For West Pharmaceutical Services (WST) Could Change Following Margin Squeeze And Slower Revenue Growth [Yahoo! Finance]Yahoo! Finance
- West Pharmaceutical Services (WST) Rebounded in Q3 [Yahoo! Finance]Yahoo! Finance
WST
Earnings
- 10/23/25 - Beat
WST
Sec Filings
- 12/10/25 - Form 4
- 12/10/25 - Form 3
- 10/31/25 - Form SCHEDULE
- WST's page on the SEC website